European Respiratory Journal · 2000 · 35 citations · 10 references
MedicineMedicinal ChemistryPharmacologyBiochemical PharmacologyInflammationPharmacodynamicsAnti-inflammatory PharmacologyAntioxidant DefenseInflammation PharmacologyInflammatory MediatorsAnti-inflammatory ResponseAntioxidant Pharmacology
Ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one), is a seleno-organic compound which protects tissues against oxidative stress. Furthermore, recent data has suggested that this compound possesses a range of anti-inflammatory properties. In this study the authors have investigated the effects of ebselen on Sephadex-induced lung oedema and bronchoalveolar lavage (BAL) tumour necrosis factor (TNF)-alpha and endothelin(ET)-1 levels in rats. Sephadex administration induced lung oedema which was accompanied by an increase in BAL TNF-alpha and ET-1 levels. Ebselen administration (1-30 mg x kg(-1), i.p. at 0, 4 and 12 h post Sephadex) significantly inhibited lung oedema (dose that produced 50% of the maximum inhibition of lung oedema 4.6 mg x kg(-1)) and BAL TNF-alpha levels in a dose-related manner with no effect on ET-1 levels. These data suggest that ebselen may be a useful therapy in lung pathologies in which bronchiolar inflammation is a feature.
10
Philippe Gosset, Anne Tsicopoulos, B Wallaert et al. · Journal of Allergy and Clinical Immunology · 1991 · 265 citations
Eridothelin immunoreactivity of airway epithelium in asthmatic patients
D.R. Springall, H. Counihan, J. M. Polak et al. · The Lancet · 1991 · 242 citations
TNFα mRNA expression in allergic inflammation
Ying Sun, David S. Robinson, Veronica Varney et al. · Clinical & Experimental Allergy · 1991 · 201 citations